Safety and Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Clinical trial NCT01416441 · COMPLETED
Trial details
- NCT number
- NCT01416441
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-19
- Primary completion
- 2014-03-13
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.